跳至主要内容
临床试验/NCT02214303
NCT02214303Unknown不适用

The Role of Th9 Cells Expression and Eosinophils Activity in the Course of Allergic Airway Diseases

Lithuanian University of Health Sciences1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Th9 cells and eosinophil apoptosis

研究概览

简要总结

The prevalence of allergic diseases, especially airway allergic diseases, has increased dramatically over the last twenty years all over the world including Lithuania. Allergic diseases are associated with significantly reduced quality of life and can sometimes cause death. Allergic diseases have turned into an important economic and social burden and nowadays take a more and more important place in the health system. Despite all intensive investigations, the pathogenesis of allergic airway diseases still remains unclear. As allergic diseases have a systemic pattern and multicomponent pathogenesis, it is important to investigate not individual cells, but examine various inflammatory cells instead, including their biological products and possible cellular interactions along the course of allergic diseases. This research focuses on the cells that are claimed to be important in the pathogenesis of allergic airway diseases, i.e. a newly found effector T helper cell subset (Th9 cells), which still lacks deeper investigation, and the main inflammatory cell, eosinophil. This study aims at determining the importance the way the Th9 lymphocytes perform, the eosinophil's activity, as well as molecular factors affecting these cells has in the process of prognostication of allergic airway diseases, namely allergic rhinitis and allergic asthma. An allergen challenge test will be performed in order to define the meaning of pathogenetic changes. The results of this research may reveal useful information in the course of allergic diseases and may be valuable when creating strategic principles of prophylaxis. The findings could be used for prevention and early diagnostics of allergic diseases and it could also open doors to discovering new and effective treatment.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Th9 cells and eosinophil apoptosis

时间窗: 24 hours after bronchial allergen challenge

Blood and sputum eosinophils also peripheral blood th9 cells will be investigated.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Raimundas Sakalauskas

prof., dr.

Lithuanian University of Health Sciences

研究点 (1)

Loading locations...

相似试验